UNSPSC 51151611: Glycopyrrolate

This classification denotes an antimuscarinic agent with the molecular formula C19H28NO3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier A14FB57V1D, chemically known as 3-hydroxy-1,1-dimethylpyrrolidinium bromide .alpha.-cyclopentylmandelate but more generally known as glycopyrrolate, which bears U.S. National Institutes of Health Compound Identifier 3494. The European Medicines Agency schedules Glycopyrronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02381MIG.

UNSPSC 51151611 Glycopyrrolate, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical scope. The single posted opportunity represents a substantial mismatch: Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, solicits Naloxone and Safe Drug Deactivation Systems—opioid-overdose reversal agents and harm-reduction equipment—rather than glycopyrrolate, an anticholinergic medication used primarily in perioperative anesthesia and chronic obstructive pulmonary disease management. The county seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under a two-year initial term with one-year renewal option. Bidders must submit electronically through the county's e-Procurement Portal with all shipping and delivery costs included; the response deadline was July 26, 2023, at 2:00 pm. Vendors must comply with drug-free workplace certification, E-Verify requirements, and federal compliance obligations tied to potential FEMA funding, including the Clean Air Act and Federal Water Pollution Control Act. The procurement carries no explicit set-aside designations.

The code shows no other recent state and local opportunities in the source. The divergence between the code's pharmaceutical classification and the actual Naloxone procurement suggests either a tagging error in the state or local jurisdiction's system or minimal routine demand for glycopyrrolate under this code at the state and local level. Absent additional opportunities, the code does not support a pursue recommendation based on current activity.